| | | Index Performance | | Index | Sensex | Nifty | | Open | 13,538.71 | 3,998.50 | | High | 13,658.11 | 4,011.00 | | Low | 13,423.64 | 3,933.35 | | Today's Cls | 13,619.70 | 3,997.65 | | Prev Cls | 13,672.19 | 4,011.60 | | Change | -52.49 | -13.95 | | % Change | -0.38 | -0.35 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | SKF India | 354.45 | 6.39 | | Apollo Tyres | 300.40 | 5.74 | | Syngenta | 588.20 | 4.91 | | Pfizer | 852.70 | 3.96 | | Sterling Biotech | 172.65 | 3.57 | | Losers | | iGate Global | 317.00 | -4.62 | | Zee Entertainment | 265.60 | -4.58 | | Arvind Mills | 45.15 | -3.53 | | ACC | 788.10 | -3.51 | | Lanco Infratech | 146.20 | -3.11 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,151 | 571 | | Declines | 1,358 | 877 | | Unchanged | 84 | 38 | | Volume(Nos) | 16.07cr | 35.85cr | | | | | | Market Commentary | | | Sensex sheds 52 points | | The weakness in the global indices triggered a fall in the domestic market and the Sensex closed with losses of 52 points for the day. | | The weakness in the global indices made the investors nervous and triggered a sell-off in the domestic market. | | | | The market opened on a bearish note at 13539, down 133 points. By mid-morning trades, the Sensex managed to pare some losses and touched an intra-day high of 13658, still down 14 points. However, the index succumbed to the selling in information technology, auto and technology stocks. Some buying at lower levels towards the close saw the Sensex recover a little and end the session with losses of 52 points at 13620 while the Nifty closed at 3998, down 14 points. | | | Movers & Shakers | - Sterling Biotech notched up gains after the company posted a year-on-year jump of 26% in its Q1 net profit.
- HCL Technologies closed in the red despite reports that the company has signed an agreement with Advanced Electronics Company (AEC) to implement information technology projects in Saudi Arabia.
- Kemrock Industries notched up gains on reports that the company has entered into a technical know-how agreement with National Aerospace Laboratories (NAL).
- Cadila Healthcare slipped despite acquiring 100% stake in Nippon Universal Pharmaceutical, Japan.
| | | |
The market breadth was weak. Of the 2,593 stocks traded on the BSE, 1,358 stocks declined, 1,151 stocks advanced and 84 stocks ended unchanged. Most of the sectoral indices ended in negative territory. The BSE IT Index was the biggest loser and slipped 1.49% at 4974 followed by the BSE Teck Index (down 0.94% at 3643) and the BSE Auto Index (down 0.69% at 4810). However, the BSE Bankex gained 0.56% at 6849 followed by the BSE FMCG Index (up 0.50% at 1812) and the BSE HC Index (up 0.29% at 3773).
Among the laggards ACC was down 3.51% at Rs788, Satyam Computers declined 2.98% at Rs448, Bajaj Auto shed 2.23% at Rs2,441, BHEL dropped 2% at Rs2,503, HDFC lost 1.91% at Rs1,564 and Infosys fell 1.84% at Rs2,040. However, select heavyweights attracted decent buying support. SBI added 1.72% at Rs1,053, ITC rose 1.24% at Rs159 and Hero Honda gained 1.10% at Rs656.
IT stocks witnessed selling pressure. Wipro dropped 1.25% at Rs579. i-flex Solutions, HCL Technologies and TCS ended with marginal losses.
Over 1.21 crore Tata Teleservices shares changed hands on the BSE followed by IFCI (97.82 lakh shares), Dish TV (81 lakh shares), GV films (67.42 lakh shares) and Advanta (58.85 lakh shares).
Advanta topped the value list with a turnover of Rs503 crore on the BSE followed by Reliance Industries (Rs205 crore), ICRA (Rs177 crore), SBI (Rs94 crore) and Aptech (Rs90 crore).
| | | | | | | | European Indices at 16:20 IST on 19-04-2007 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 | 6409.40 | -40.00 | -0.62 | | CAC 40 Index | 5787.55 | -48.40 | -0.83 | | DAX Index | 7196.58 | -85.76 | -1.18 | | | | | | | | | | | Asian Indices at close on 19-04-2007 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 17371.97 | -295.36 | -1.67 | | Hang Seng | 20299.71 | -477.38 | -2.30 | | Kospi Index | 1513.66 | -20.92 | -1.36 | | Straits Times Index | 3291.28 | -109.13 | -3.21 | | Jakarta Composite Index | 1918.35 | -41.32 | -2.11 | | | | | | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com
| |
No comments:
Post a Comment